These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31783863)

  • 1. Ultrasmall nanostructured drug based pH-sensitive liposome for effective treatment of drug-resistant tumor.
    Li Y; Zhai Y; Liu W; Zhang K; Liu J; Shi J; Zhang Z
    J Nanobiotechnology; 2019 Nov; 17(1):117. PubMed ID: 31783863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near-infrared light-sensitive liposomes for the enhanced photothermal tumor treatment by the combination with chemotherapy.
    You J; Zhang P; Hu F; Du Y; Yuan H; Zhu J; Wang Z; Zhou J; Li C
    Pharm Res; 2014 Mar; 31(3):554-65. PubMed ID: 24022681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
    Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH
    J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
    Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D
    Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.
    Fernandes RS; Silva JO; Monteiro LOF; Leite EA; Cassali GD; Rubello D; Cardoso VN; Ferreira LAM; Oliveira MC; de Barros ALB
    Biomed Pharmacother; 2016 Dec; 84():252-257. PubMed ID: 27664949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model.
    Zahmatkeshan M; Gheybi F; Rezayat SM; Jaafari MR
    Eur J Pharm Sci; 2016 Apr; 86():125-35. PubMed ID: 26972276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated hyaluronidase/NIR induced drug controlled release system for synergetic chemo-photothermal therapy of hepatocellular carcinoma.
    Li H; Li H; Yu W; Huang S; Liu Y; Zhang N; Yuan J; Xu X; Duan S; Hu Y
    Eur J Pharm Sci; 2019 May; 133():127-136. PubMed ID: 30779981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Long-circulating DOX Liposome: Formulation and Pharmacokinetics Studies.
    Xiao P; Zhao J; Huang Y; Jin R; Tang Z; Wang P; Song X; Zhu H; Yang Z; Yu N
    Pharm Nanotechnol; 2020; 8(5):391-398. PubMed ID: 32787769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Tailored DNA Nanoplatform for Synergistic RNAi-/Chemotherapy of Multidrug-Resistant Tumors.
    Liu J; Song L; Liu S; Zhao S; Jiang Q; Ding B
    Angew Chem Int Ed Engl; 2018 Nov; 57(47):15486-15490. PubMed ID: 30288887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers.
    Cao C; Wang Q; Liu Y
    Drug Des Devel Ther; 2019; 13():1087-1098. PubMed ID: 31118562
    [No Abstract]   [Full Text] [Related]  

  • 12. Fullerene (C60)-based tumor-targeting nanoparticles with "off-on" state for enhanced treatment of cancer.
    Shi J; Wang B; Wang L; Lu T; Fu Y; Zhang H; Zhang Z
    J Control Release; 2016 Aug; 235():245-258. PubMed ID: 27276066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
    Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
    Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulation of Stimuli-Responsive and Stoichiometrically Controlled Release Rate of Doxorubicin from Liposomes in Tumor Interstitial Fluid.
    Yamamoto E; Hyodo K; Suzuki T; Ishihara H; Kikuchi H; Kato M
    Pharm Res; 2018 Mar; 35(5):103. PubMed ID: 29557075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects.
    Lages EB; Fernandes RS; Andrade MMS; Paiyabhroma N; de Oliveira RB; Fernandes C; Cassali GD; Sicard P; Richard S; Branco de Barros AL; Ferreira LAM
    Biomed Pharmacother; 2021 Dec; 144():112373. PubMed ID: 34794238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer.
    VanOsdol J; Ektate K; Ramasamy S; Maples D; Collins W; Malayer J; Ranjan A
    J Control Release; 2017 Feb; 247():55-63. PubMed ID: 28042085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin.
    Tagami T; Ernsting MJ; Li SD
    J Control Release; 2011 Jun; 152(2):303-9. PubMed ID: 21338635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular structural transformation regulated dynamic disordering of supramolecular vesicles as pH-responsive drug release systems.
    Liu Y; Gao FP; Zhang D; Fan YS; Chen XG; Wang H
    J Control Release; 2014 Jan; 173():140-7. PubMed ID: 24188958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIR-/pH-Responsive drug delivery of functionalized single-walled carbon nanotubes for potential application in cancer chemo-photothermal therapy.
    Wang L; Shi J; Jia X; Liu R; Wang H; Wang Z; Li L; Zhang J; Zhang C; Zhang Z
    Pharm Res; 2013 Nov; 30(11):2757-71. PubMed ID: 23765399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.